Comparison of Contemporary Surgical Outcomes Between Holmium Laser Enucleation of the Prostate and Robotic-Assisted Simple Prostatectomy.
T Max SheltonConnor DrakeRuben VasquezMarcelino E RiveraPublished in: Current urology reports (2023)
RASP is indicated for prostates > 80 mL, while HoLEP is size-independent. No notable differences were found in operative time, PSA nadir (surrogate for enucleation volume), re-catheterization rates, or long-term durability. Prolonged incontinence and bladder neck contracture rates are low for both surgeries. Patients experience similar satisfaction outcomes and improvements in uroflowmetry and post-void residual volumes. HoLEP demonstrates shorter hospitalizations, lower transfusion rates, lower costs, and higher rates of same-day discharge. RASP offers a shorter learning curve and lower rates of early postoperative urinary incontinence. HoLEP is a size-independent surgery that offers advantages for patients seeking a minimally invasive procedure with the potential for catheter-free same-day discharge. Future directions with single-port simple prostatectomy may offer parity in same-day discharge, but further research is needed to determine broader feasibility.
Keyphrases
- minimally invasive
- end stage renal disease
- prostate cancer
- benign prostatic hyperplasia
- urinary incontinence
- ejection fraction
- robot assisted
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- spinal cord injury
- mass spectrometry
- high resolution
- risk assessment
- climate change
- acute coronary syndrome
- urinary tract